Strategic intelligence for the pet industry
Exclusive interviews, competitive analysis, and insights on the deals, innovations, and strategies reshaping the market — delivered while it still matters.
By clicking Subscribe you're confirming that you agree with our Terms and Conditions.
.jpg)
Read by 15K+ industry professionals
Interviews
We sit down with founders, operators, and investors to talk through how pet businesses actually get built. The conversations cover origin stories, inflection points, hard decisions, and the thinking behind what worked and what didn’t.
Inside the $10M Fund Backing Pet-Tech Founders
Alex Chieng, co-founder and CEO of Pawsible Ventures, breaks down the thesis behind Pawsible’s inaugural $10M fund, how its global incubator supports early pet-tech founders, and why founder–market fit, longevity, and data-driven pet health are at the center of the next wave of PetTech innovation.
The Operational Blueprint Behind Wag's Growth
Jason Meltzer, co-founder and former CEO of Wag!, reflects on building one of the first breakout pet services platforms—raising $400M, scaling nationwide, and learning the hard lessons of trust, logistics, and growth—before turning his attention to a new category: pet-first living with Live Work Pet.
Racing the FDA for Stem Cell Approval
How Gallant's CEO rebuilt after the founder's death and engineered a 30-million-dose breakthrough that could make them the first company to win FDA approval for off-the-shelf stem cell therapy in veterinary medicine — with $40 million raised and a proprietary manufacturing process that turns discarded tissue into treatments accessible to every clinic.
Why people keep reading
The Underbite is read by founders, operators, and investors across the pet industry. Here’s what a few of them have said about why it’s become part of their weekly routine.
Why Subscribe
Subscribers get full access to The Underbite’s reporting, interviews, and analysis built for people making real decisions in the pet industry. Less noise, more signal, and a clearer view of what’s actually driving growth.
280+
Deep dives, roundups, and insights published
The strategy layer
Category shifts. Competitive positioning. Partnership plays. The analysis that actually changes how you operate.
3x
Weekly – Monday, Wednesday, Friday
100+
Founder, operator, investor conversations published
What actually happened this week
Deals, launches, hires, and moves that matter – with context on why and what to watch next.
5 min
To know what matters - replaces doomscrolling
What's happening
The latest from pet companies — from early-stage startups to legacy brands making moves.
A second freeze-dry plant gives Golden Pet a structural cost advantage over its DTC peers
Golden Pet Brands acquired Scoular's Petsource freeze-dried pet food plant in Seward, Nebraska — a $130M-capex facility that served as a contract manufacturer for much of the indie freeze-dry market. The deal vertically integrates the Dr. Marty, Badlands Ranch, and Ultimate Pet Nutrition portfolio and tightens supply for competitors.
Gallant Posts Pilot Data on IV Stem Cell Therapy for Canine OA, Wins Expanded FDA Conditional Approval Eligibility
Pilot data from Gallant on its IV-delivered stem cell therapy for canine osteoarthritis showed statistically significant improvement, and the company won expanded FDA conditional approval eligibility targeting 2028. Pet pharma just entered its biotech era.
Rover's Summer Survey: Hotels Get Cheaper, Pet Care Stays Premium
Rover's new summer travel survey of 1,000 U.S. pet parents shows 92% will travel but are trading down hotels, flights, and trip length while keeping pet care premium. For hotel chains, airlines, and the pet boarding marketplace, the recession-resistant pattern in pet care spend is the operator signal worth tracking three weeks before Memorial Day weekend.
Topics
Long-form analysis across six areas shaping how pet companies grow and compete.
.svg)
Technology
Software, hardware, AI, and connected devices changing how pets are cared for and how companies operate
Finance
Funding rounds, M&A, valuations, and the capital flows shaping who wins and who exits.
Product Development
Formulation, sourcing, packaging, and the decisions behind what actually gets to market.
Marketing
Brand positioning, customer acquisition, retention strategies, and the campaigns worth studying.
Operations
Supply chain, logistics, fulfillment, and the infrastructure behind scaling a pet business.
Regulatory
FDA, AAFCO, labeling requirements, and the compliance landscape companies need to navigate.